LogiPharma Launches 2024 Agenda Featuring Big Pharma Players
LogiPharma has unveiled its highly anticipated 2024 agenda, spotlighting key themes and speakers for this year's show, which takes place in Lyon, France, 16th – 18th April.
Union Cabinet Approves MoI Between India's CDSCO and Netherlands
The MoI, signed on 7th November 2023, sets the stage for collaborative efforts in the field of Medical Products Regulation.
The agreement aims to promote the exchange of information and collaboration in areas related to medical products, as well as administrative and regulatory matters within the jurisdictions of both parties.
Technical Drying Services Celebrates 25 Years of Empowering Industries
On the occasion of the silver jubilee, the company pledged to boost its innovative endeavors to amplify its leadership position in providing quality air solutions.
Bayer and Sun Pharma Sign Marketing Agreement for Second Brand of Finerenone in India
Under the terms of the agreement, Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa. Finerenone was first launched by Bayer under the brand name Kerendia in 2022.
Torque Pharma Unveiles Transformative Brand Identity Under the Theme 'Better Together'
This strategic rebranding, initiated in 2024 with a fresh team and forward vision, signifies Torque Pharma's commitment to fostering collaboration, synergy, and unity in delivering innovative and high-quality healthcare solutions. The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme.
Asia-Pacific Pharmaceutical Logistics Market Set to Surge at 6.68 Percent CAGR
According to a comprehensive analysis, the market size is anticipated to swell from USD 143.22 billion in 2023 to an impressive USD 197.94 billion by 2028.
First US VasQ Implantation Signals Breakthrough in Vascular Access Surgery
VasQ™, a nitinol-based external support device, plays a crucial role in the surgical creation of an arteriovenous fistula to facilitate maturation into functional access for hemodialysis.
Willow Biosciences and Enterin Join Forces for Sustainable Pharmaceutical Manufacturing
Willow Biosciences Inc. has announced a groundbreaking collaboration with Enterin, Inc., a clinical-stage biopharmaceutical company at the forefront of developing innovative treatments targeting neurodegenerative and metabolic disorders.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy